Screener
Edwards Lifesciences EW Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
FAQ
- What is Edwards Lifesciences's operating lease liabilities (current)?
- Edwards Lifesciences (EW) reported operating lease liabilities (current) of $24.3M in Q1 2026.
- How has Edwards Lifesciences's operating lease liabilities (current) changed year-over-year?
- Edwards Lifesciences's operating lease liabilities (current) increased by 2.5% year-over-year, from $23.7M to $24.3M.
- What is the long-term trend for Edwards Lifesciences's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Edwards Lifesciences's operating lease liabilities (current) has grown at a -2.1% compound annual growth rate (CAGR), from $27.2M to $24.5M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Edwards Lifesciences's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude